Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting Stents
Top Cited Papers
- 12 July 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 112 (2) , 270-278
- https://doi.org/10.1161/circulationaha.104.508937
Abstract
Background— Although effective coverage of challenging coronary lesions has warranted the use of overlapping drug-eluting stents, the histopathological response to stent overlap is unknown.Keywords
This publication has 20 references indexed in Scilit:
- Physical characterization of controlled release of paclitaxel from the TAXUS™ Express2™ drug‐eluting stentJournal of Biomedical Materials Research Part A, 2004
- Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary modelCardiovascular Research, 2004
- Vascular Healing 4 Years After the Implantation of Sirolimus-Eluting Stent in HumansCirculation, 2004
- Very long sirolimus-eluting stent implantation for de novo coronary lesionsThe American Journal of Cardiology, 2004
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003
- Preliminary Observations Regarding Angiographic Pattern of Restenosis After Rapamycin-Eluting Stent ImplantationCirculation, 2003
- Drug-Eluting Stents in Preclinical StudiesCirculation, 2002
- First Clinical Experience With a Paclitaxel Derivate–Eluting Polymer Stent System Implantation for In-Stent RestenosisCirculation, 2002
- Clinical and angiographical follow-up after implantation of a 6–12μCi radioactive stent in patients with coronary artery diseasePublished by Oxford University Press (OUP) ,2001